Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 01-Oct-24 9:00 PM View:  | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Sep-24 | Payment of Exercise | 2,340 | $11.48 | $26,863.20 | (< 1%) 283.62K to 281.28K | |
| 26-Sep-24 9:22 PM View: | Qvt Financial Lp | Roivant Sciences Ltd. (ROIV) | 26-Sep-24 | Sale Duplicate | 876,000 | $11.82 | $10,354,300.00 | (1%) 66.67M to 65.79M | |
| 26-Sep-24 8:34 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 26-Sep-24 | Sale | 876,000 | $11.82 | $10,354,300.00 | (3%) 29.5M to 28.62M | |
| 26-Sep-24 9:22 PM View: | Qvt Financial Lp | Roivant Sciences Ltd. (ROIV) | 25-Sep-24 | Private Sale | 50,000 | $11.77 | $588,500.00 | (< 1%) 66.72M to 66.67M | |
| 26-Sep-24 8:34 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 25-Sep-24 | Sale | 415,551 | $11.77 | $4,889,320.00 | (1%) 29.92M to 29.5M | |
| 26-Sep-24 8:35 PM View: | Manchester Keith S Director | Roivant Sciences Ltd. (ROIV) | 25-Sep-24 | Sale | 134,948 | $11.77 | $1,587,700.00 | (10%) 1.41M to 1.28M | |
| 26-Sep-24 8:34 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 25-Sep-24 | Sale | 991,593 | $11.77 | $11,666,400.00 | (3%) 30.91M to 29.92M | |
| 26-Sep-24 8:34 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 24-Sep-24 | Private Sale | 1,565,670 | $11.62 | $18,200,900.00 | (5%) 33.05M to 31.48M | |
| 26-Sep-24 8:35 PM View: | Manchester Keith S Director | Roivant Sciences Ltd. (ROIV) | 24-Sep-24 | Private Sale | 368,052 | $11.62 | $4,278,600.00 | (21%) 1.78M to 1.41M | |
| 26-Sep-24 8:34 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 24-Sep-24 | Sale | 577,186 | $11.62 | $6,709,790.00 | (2%) 31.48M to 30.91M | |
| 24-Sep-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Option Sale | 1,550,000 | $11.79 | $18,274,500.00 | (8%) 19.36M to 17.81M | |
| 24-Sep-24 9:01 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Option Exercise | 250,000 | $3.85 | $962,500.00 | 119% 209.32K to 459.32K | |
| 24-Sep-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Disposition (other) | 498,539 | $11.97 | $5,967,510.00 | (3%) 19.85M to 19.36M | |
| 24-Sep-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Sale | 433,257 | $11.79 | $5,108,100.00 | (2%) 17.81M to 17.37M | |
| 24-Sep-24 9:01 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Option Sale | 250,000 | $11.89 | $2,972,500.00 | (54%) 459.32K to 209.32K | |
| 24-Sep-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 23-Sep-24 | Option Exercise | 1,550,000 | $3.85 | $5,967,500.00 | 8% 18.3M to 19.85M | |
| 24-Sep-24 9:01 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Sep-24 | Payment of Exercise | 10,945 | $11.97 | $131,012.00 | (< 1%) 18.31M to 18.3M | |
| 24-Sep-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Sep-24 | Payment of Exercise | 10,945 | $11.97 | $131,012.00 | (2%) 639.36K to 628.41K | |
| 24-Sep-24 9:01 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 20-Sep-24 | Payment of Exercise | 2,129 | $11.97 | $25,484.10 | (< 1%) 285.75K to 283.62K | |
| 24-Sep-24 9:01 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Sep-24 | Payment of Exercise | 3,087 | $11.97 | $36,951.40 | (1%) 212.41K to 209.32K | |
| 16-Sep-24 9:00 PM View: | Fitzgerald Meghan Director | Roivant Sciences Ltd. (ROIV) | 12-Sep-24 | Disposition (other) | 894 | $12.12 | $10,835.30 | (3%) 30.27K to 29.38K | |
| 16-Sep-24 9:00 PM View: | Momtazee James C Director | Roivant Sciences Ltd. (ROIV) | 12-Sep-24 | Disposition (other) | 3,056 | $12.12 | $37,038.70 | (3%) 95.49K to 92.43K | |
| 16-Sep-24 9:00 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 12-Sep-24 | Disposition (other) | 4,245 | $12.12 | $51,449.40 | (10%) 40.67K to 36.42K | |
| 16-Sep-24 9:00 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 12-Sep-24 | Disposition (other) | 3,487 | $12.12 | $42,262.40 | (4%) 99.04K to 95.55K | |
| 16-Sep-24 9:00 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 12-Sep-24 | Disposition (other) | 2,599 | $12.12 | $31,499.90 | (< 1%) 9.95M to 9.95M | |
| 12-Sep-24 9:00 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | 68% 24.26K to 40.67K | |
| 12-Sep-24 9:00 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | 20% 82.63K to 99.04K | |
| 12-Sep-24 9:00 PM View: | Gold Daniel Allen Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | < 1% 9.93M to 9.95M | |
| 12-Sep-24 9:00 PM View: | Fitzgerald Meghan Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | 118% 13.86K to 30.27K | |
| 12-Sep-24 9:00 PM View: | Momtazee James C Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | 21% 79.08K to 95.49K | |
| 12-Sep-24 9:00 PM View: | Manchester Keith S Director | Roivant Sciences Ltd. (ROIV) | 10-Sep-24 | Grant | 16,406 | -- | -- | < 1% 1.76M to 1.78M | |
| 30-Aug-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Aug-24 | Payment of Exercise | 2,341 | $12.00 | $28,092.00 | (< 1%) 288.09K to 285.75K | |
| 22-Aug-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Aug-24 | Payment of Exercise | 10,947 | $11.48 | $125,672.00 | (2%) 650.31K to 639.36K | |
| 22-Aug-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Aug-24 | Payment of Exercise | 958 | $11.48 | $10,997.80 | (< 1%) 213.37K to 212.41K | |
| 22-Aug-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Aug-24 | Payment of Exercise | 10,947 | $11.48 | $125,672.00 | (< 1%) 18.33M to 18.31M | |
| 30-Jul-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Jul-24 | Payment of Exercise | 2,341 | $10.80 | $25,282.80 | (< 1%) 290.43K to 288.09K | |
| 30-Jul-24 9:01 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 26-Jul-24 | Grant | 204,000 | -- | -- | 46% 446.31K to 650.31K | |
| 30-Jul-24 9:04 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 26-Jul-24 | Grant | 17,204,800 | -- | -- | 1535% 1.12M to 18.33M | |
| 30-Jul-24 9:02 PM View: | Sukhatme Mayukh Pres&Chief Investment Officer Director | Roivant Sciences Ltd. (ROIV) | 26-Jul-24 | Grant | 18,836,500 | -- | -- | 355% 5.31M to 24.15M | |
| 25-Jul-24 9:00 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 23-Jul-24 | Payment of Exercise | 215 | $11.01 | $2,367.15 | (< 1%) 82.85K to 82.63K | |
| 25-Jul-24 9:00 PM View: | Oren Ilan Director | Roivant Sciences Ltd. (ROIV) | 23-Jul-24 | Grant | 2,440 | -- | -- | 3% 80.41K to 82.85K | |
| 25-Jul-24 9:00 PM View: | Epperly Melissa B, Director | Roivant Sciences Ltd. (ROIV) | 23-Jul-24 | Grant | 1,702 | -- | -- | 8% 22.56K to 24.26K | |
| 25-Jul-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Jul-24 | Payment of Exercise | 10,945 | $11.00 | $120,395.00 | (2%) 457.25K to 446.31K | |
| 25-Jul-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Jul-24 | Payment of Exercise | 958 | $11.00 | $10,538.00 | (< 1%) 214.32K to 213.37K | |
| 25-Jul-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Jul-24 | Payment of Exercise | 10,945 | $11.00 | $120,395.00 | (< 1%) 1.13M to 1.12M | |
| 01-Jul-24 9:01 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 28-Jun-24 | Payment of Exercise | 2,340 | $10.57 | $24,733.80 | (< 1%) 292.77K to 290.43K | |
| 24-Jun-24 9:00 PM View: | Gline Matthew CEO Director | Roivant Sciences Ltd. (ROIV) | 20-Jun-24 | Payment of Exercise | 10,945 | $10.80 | $118,206.00 | (< 1%) 1.14M to 1.13M | |
| 24-Jun-24 9:00 PM View: | Pulik Richard CFO | Roivant Sciences Ltd. (ROIV) | 20-Jun-24 | Payment of Exercise | 2,129 | $10.80 | $22,993.20 | (< 1%) 292.7K to 290.57K | |
| 24-Jun-24 9:00 PM View: | Venker Eric President & COO | Roivant Sciences Ltd. (ROIV) | 20-Jun-24 | Payment of Exercise | 10,945 | $10.80 | $118,206.00 | (2%) 468.2K to 457.25K | |
| 24-Jun-24 9:00 PM View: | Kumar Rakhi Chief Accounting Officer | Roivant Sciences Ltd. (ROIV) | 20-Jun-24 | Payment of Exercise | 3,087 | $10.80 | $33,339.60 | (1%) 215.21K to 212.12K |
